Turnstone Biologics Corp. (TSBX) has 2 open-market insider trades by 2 insiders since 2023. The most active filer is Rishi Gupta, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Rishi Gupta | Dir10% Owner | — | 1 | $5.0M | 2025-08-08 |
| Davis Jerel | Dir10% Owner | — | 1 | $2.7M | 2025-08-08 |
| Orbimed Advisors LLC | Dir10% Owner | — | 0 | — | 2025-08-08 |
| Versant Venture Capital V, L.P. | 10% Owner | — | 0 | — | 2025-08-08 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Davis Jerel | Director & 10% Owner | Buy | $2.7M | 2023-07-25 |
| Rishi Gupta | Director & 10% Owner | Buy | $5.0M | 2023-07-20 |
Companies that share insiders with TSBX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.